Earnings Feed
Start Free
Opus Genetics, Inc.·4

Apr 27, 4:27 PM ET

Zaremba Rabourn Amy 4

Research Summary

AI-generated summary

Updated

Opus Genetics (IRD) Head of Financial QA Amy Zaremba Rabourn Sells Shares

What Happened
Amy Zaremba Rabourn, Head of Financial Quality Assurance at Opus Genetics (IRD), disposed of 1,641 shares on April 23, 2026. The shares were sold at a weighted average price of $5.20 per share for total proceeds of approximately $8,540. The filing clarifies this was an automatic sale to satisfy tax withholding obligations arising from a restricted stock unit (RSU) vesting and settlement event, not a discretionary trade by the insider.

Key Details

  • Transaction date: 2026-04-23; Form 4 filed 2026-04-27 (appears timely within the two-business-day filing window).
  • Sale type/code: S (sale); Reason: automatic tax withholding related to RSU vesting (footnote F1).
  • Price details: weighted average $5.20; shares sold in multiple trades at prices between $5.2038 and $5.2051 (footnote F2). The reporting person can provide a per-trade breakdown on request.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Filing accession: 0000905148-26-001865; Period of report: 2026-04-23.

Context
This was a tax-withholding sale tied to RSU settlement (routine), which typically does not indicate the insider’s view on the company’s prospects. The transaction value is relatively small (~$8.5k), so it’s unlikely to be materially informative about insider sentiment.